Over-the-counter drug · ANDA
Fexofenadine Hydrochloride NDC 73581-027
Fexofenadine hydrochloride 180 mg/1 · Tablet · Oral · YYBA Corp
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 73581-027-01 | 73581002701 | 10 TABLET in 1 BOTTLE (73581-027-01)Marketed from Oct 3, 2025 | |
| 73581-027-04 | 73581002704 | 40 TABLET in 1 BOTTLE (73581-027-04)Marketed from Oct 3, 2024 | |
| 73581-027-10 | 73581002710 | 100 TABLET in 1 BOTTLE (73581-027-10)Marketed from Oct 3, 2025 | |
| 73581-027-20 | 73581002720 | 200 TABLET in 1 BOTTLE (73581-027-20)Marketed from Oct 29, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Fexofenadine Hydrochloride
- Generic name (nonproprietary)
- fexofenadine hydrochloride
- Active ingredients
- Fexofenadine hydrochloride — 180 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- YYBA Corp
- Product type
- Over-the-counter drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 210137
- Marketing start
- Listing expires
- Other FDA classes
- Histamine H1 Receptor Antagonists (Mechanism)
- Identifiers
- Product ID 73581-027_53fea010-2c55-9819-e063-6394a90a103eSPL ID 53fea010-2c55-9819-e063-6394a90a103eSPL set ID 53fe8ef5-ab65-f23e-e063-6394a90a30f0RxCUI 997420UNII 2S068B75ZU
- Pharmacologic class
- Histamine-1 Receptor Antagonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N473581002701followed by a unit qualifier and the quantityPackage 73581-0027-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Uses temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 210137
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| FEXOFENADINE HCl | Fexofenadine hydrochloride 180 mg/1 | Tablet, Film coatedOral | Strategic Sourcing Services, LLC | 70677-1239 |
| Fexofenadine Hydrochloride | Fexofenadine hydrochloride 180 mg/1 | TabletOral | Pioneer Life Sciences, LLC | 72090-010 |
| Fexofenadine Hydrochloride | Fexofenadine hydrochloride 180 mg/1 | TabletOral | Pioneer Life Sciences, LLC | 72090-010 |
| Fexofenadine Hydrochloride | Fexofenadine hydrochloride 180 mg/1 | TabletOral | Pioneer Life Sciences, LLC | 72090-010 |
| CVS Fexofenadine Hydrochloridefexofenadine hydrochloride | Fexofenadine hydrochloride 180 mg/1 | TabletOral | CVS Pharmacy | 51316-183 |
| Gencare Hives Relieffexofenadine hydrochloride | Fexofenadine hydrochloride 180 mg/1 | TabletOral | Pioneer Life Sciences, LLC | 72090-058 |
| Fexofenadine Hydrochloride | Fexofenadine hydrochloride 180 mg/1 | TabletOral | NUVICARE LLC | 84324-008 |
| Fexofenadine Hydrochloride | Fexofenadine hydrochloride 180 mg/1 | TabletOral | NUVICARE LLC | 84324-008 |
| Nuvicare Hives Relieffexofenadine hydrochloride | Fexofenadine hydrochloride 180 mg/1 | TabletOral | NUVICARE LLC | 84324-031 |